Impaired awareness of hypoglycemia in adults with type 1 diabetes is not associated with autonomic dysfunction or peripheral neuropathy

Diabetes Care

Volumn 39, Issue 3, 2016, Pages 426-433

  Olsen, Sandra E ^a   Bjørgaas, Marit R ^a,b   Åsvold, Bjørn O ^a,b   Sand, Trond ^a,b   Stjern, Marit ^a,b   Frier, Brian M ^c   Nilsen, Kristian B ^a,d,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPOGLYCEMIA; IMPAIRED AWARENESS OF HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSORY NERVE CONDUCTION; SEX DIFFERENCE; THERMAL ANALYSIS; AUTONOMIC NEUROPATHY; AWARENESS; DIABETIC NEUROPATHY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; AWARENESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; RISK FACTORS;

EID: 84962076508     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1469     Document Type: Article

References (39)

1. Graveling AJ, Frier BM. Impaired awareness of hypoglycaemia: a review. Diabetes Metab 2010;36(Suppl. 3):S64-S74
2. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypo-glycaemia in adults with type 1 diabetes. Diabet Med 2008;25:501-504
3. Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract 2010; 87:64-68
4. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes2005;54:3592-3601
5. Fanelli C, Pampanelli S, Epifano L, et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitivedysfunc-tion during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 1994;37:1265-1276
6. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994;344:283-287
7. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994;43:1426-1434
8. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991;8: 217-222
9. Olsen SE, Asvold BO, Frier BM, Aune SE, Hansen LI, Bjørgaas MR. Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration. Diabet Med 2014;31: 1210-1217
10. Frier BM. Impaired awareness of hypogly-cemia. In Hypoglycemia in Clinical Diabetes. Frier BM, McCrimmon RJ, Eds. Chichester, West Sussex, John Wiley & Sons Ltd, 2014, p. 114-144
11. Stephenson JM, Kempler P, Perin PC, Fuller JH. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 1996;39: 1372-1376
12. Hilsted J, Richter E, Madsbad S, et al. Metabolic and cardiovascular responses to epineph-rine in diabetic autonomic neuropathy. N Engl J Med 1987;317:421-426
13. Hepburn DA, MacLeod KM, Frier BM. Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy. Diabet Med 1993;10:940-949
14. Bottini P, Boschetti E, Pampanelli S, et al. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypogly-cemia in IDDM: evidence for a nonselective defect. Diabetes 1997;46:814-823
15. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypogly-cemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993;91:819-828
16. Fanelli C, Pampanelli S, Lalli C, et al. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregula-tion. Diabetes 1997;46:1172-1181
17. Meyer C, Grossmann R, Mitrakou A, et al. Effects of autonomic neuropathy on counterre-gulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care 1998; 21:1960-1966
18. DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 2004; 287:E32-E41
19. Gonder-Frederick L, Cox D, Kovatchev B, Schlundt D, Clarke W. A biopsychobehavioral model of risk of severe hypoglycemia. Diabetes Care 1997;20:661-669
20. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypogly-cemia. Diabetes Care 1994;17:697-703
21. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995;18:517-522
22. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ 1990;301:783-787
23. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypogly-caemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 1990;7:711-717
24. Geddes J, Wright RJ, Zammitt NN, Deary IJ, Frier BM. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care 2007;30:1868-1870
25. Low PA. Testing the autonomic nervous system. Semin Neurol 2003;23:407-421
26. England JD, Gronseth GS, Franklin G, et al.; American Academy of Neurology; American Association of Neuromuscular and Electro-diagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 2009;39:106-115
27. Heise CO, Machado FC, Amorim SC, Toledo SM. Combined nerve conduction index in diabetic polyneuropathy. Arq Neuropsiquiatr 2012; 70:330-334
28. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 2009;58:360-366
29. Zilliox L, Peltier AC, Wren PA, et al. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 2011;76:1099-1105
30. Dyck PJ, Albers JW, Andersen H, et al.; Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011;27: 620-628
31. Vogel ER, Corfits JL, Sandroni P, et al. Effect of position on Valsalva maneuver: supine versus 20 degree position. J Clin Neurophysiol 2008;25: 313-316
32. Spallone V, Bellavere F, Scionti L, et al.; Diabetic Neuropathy Study Group of the Italian Society of Diabetology. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 2011;21:69-78
33. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003;19: 232-240
34. Speight J, Barendse SM, Singh H, et al. Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q). Diabet Med. 4 June 2015 [Epub ahead of print]. DOI: 10.1111/dme.12824
35. Janssen MM, Snoek FJ, Heine RJ. Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care 2000;23:529-532
36. Maguire AM, Craig ME, Craighead A, et al. Autonomic nerve testing predicts the development of complications: a 12-year follow-up study. Diabetes Care 2007;30:77-82
37. Kamel JT, Goodman DJ, Howe K, Cook MJ, Ward GM, Roberts LJ. Assessment of the relationship between hypoglycaemia awareness and autonomic function following islet cell/pancreas transplantation. Diabetes Metab Res Rev 2015;31:646-650
38. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95-108
39. Clarke BF, Ewing DJ, Campbell IW. Diabetic autonomic neuropathy. Diabetologia 1979;17: 195-212